These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 769631)

  • 1. Leukotactic dystunction in sarcoidosis.
    Maderazo EG; Ward PA; Woronick CL; Kubik J; DeGraff AC
    Ann Intern Med; 1976 Apr; 84(4):414-9. PubMed ID: 769631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective regulation of chemotaxis in cirrhosis.
    Maderazo EC; Ward PA; Quintiliani R
    J Lab Clin Med; 1975 Apr; 85(4):621-30. PubMed ID: 1120929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical quantitation of the chemotactic factor inactivator activity in human serum.
    Fantone J; Senior RM; Kreutzer DL; Jones M; Ward PA
    J Lab Clin Med; 1979 Jan; 93(1):17-24. PubMed ID: 759526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.
    Ward PA; Berenberg JL
    N Engl J Med; 1974 Jan; 290(2):76-80. PubMed ID: 4855544
    [No Abstract]   [Full Text] [Related]  

  • 5. Defective leukotaxis in patients with lepromatous leprosy.
    Ward PA; Goralnick S; Bullock WE
    J Lab Clin Med; 1976 Jun; 87(6):1025-32. PubMed ID: 778311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective monocyte leukotaxis in sarcoidosis: possible relationship to a plasma factor.
    Campbell PB
    Am Rev Respir Dis; 1977 Aug; 116(2):251-9. PubMed ID: 329726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective leukotaxis in patients with lepromatous leprosy.
    Ward PA; Goralnick S; Bullock WE
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):243-9. PubMed ID: 945238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Chemotactic-factor inactivator in Hodgkin's disease.
    Saccoccia P
    N Engl J Med; 1974 Apr; 290(16):913-4. PubMed ID: 4816976
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.
    Chase MW
    Cancer Res; 1966 Jun; 26(6):1097-120. PubMed ID: 4161706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibition of leukocyte migration in tuberculosis and diseases with cutaneous energy].
    Lenzini L; Rottoli L; Rottoli P
    Ann Sclavo; 1974; 16(1):29-56. PubMed ID: 4529204
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
    Orr W; Varani J; Ward PA
    Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer factor deficiency response--a mechanism of anergy in Boeck's sarcoid.
    Lawrence HS; Zweiman B
    Trans Assoc Am Physicians; 1968; 81():240-8. PubMed ID: 5721403
    [No Abstract]   [Full Text] [Related]  

  • 15. Leucocyte-migration test in sarcoidosis.
    Becker FW; Krull P; Deicher H; Kalden JR
    Lancet; 1972 Jan; 1(7742):120-3. PubMed ID: 4108983
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotactic factor inactivator in normal human serum.
    Berenberg JL; Ward PA
    J Clin Invest; 1973 May; 52(5):1200-6. PubMed ID: 4121701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basophilic granulocyte reaction in common inflammation and in delayed-type immune reaction].
    Kohout J
    Wien Klin Wochenschr; 1972 Dec; 84(52):841-3. PubMed ID: 4651912
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of lymphocytes and immune lymphocytes in sarcoidosis and in malignant lymphadenomas.
    Kohout J
    Postgrad Med J; 1975 Jun; 51(596):396-8. PubMed ID: 1215254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human C 1 inhibitor on complement-mediated human leukocyte chemotaxis.
    Smith CW; Hollers JC; Bing DH; Patrick RA
    J Immunol; 1975 Jan; 114(1 Pt 1):216-20. PubMed ID: 1167560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disturbance of the cellular defense in sarcoidosis].
    Kohout J
    Med Klin; 1971 Dec; 66(51):1765-9. PubMed ID: 5135974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.